Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897962 · ClinicalTrials.gov registry record
Blood Glycan Biomarkers in Women With Stage IV Breast Cancer
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 163
- Enrollment target
NCT00897962 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 163 participants.
The verdict
NCT00897962 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.
Interventions
- OTHER Healthy Controls
- OTHER Metastatic Breast Cancer
- OTHER Non-cancer medical illness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2006-09 |
| Est. Completion | 2016-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897962
The ClinicalTrials.gov registry entry for NCT00897962 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Healthy Controls is the first listed.
NCT00897962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897962 about?
NCT00897962 is a clinical study titled "Blood Glycan Biomarkers in Women With Stage IV Breast Cancer". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.
What is the current status of trial NCT00897962?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2006-09. Estimated completion is 2016-01-12.
What interventions are being tested in trial NCT00897962?
The interventions under investigation include: Healthy Controls (OTHER), Metastatic Breast Cancer (OTHER), Non-cancer medical illness (OTHER).
Who is sponsoring clinical trial NCT00897962?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.